[1]
“Assessment of Efficacy and Safety of Tirofiban in Acute Coronary Syndrome Patients Following Percutaneous Coronary Intervention: A Prospective Observational Study”, The Insight, vol. 9, no. 01, pp. 167–171, Mar. 2026, doi: 10.5281/.